Research graph
References from Angiotensin receptor–neprilysin inhibitor versus angiotensin-converting enzyme inhibitor for osteoporosis risk in patients with heart failure. Local targets link to admitted publications; unresolved targets remain external evidence.
10.15420/cfr.2024.39
10.15420/cfr.2024.39 · 2025 · External reference
10.36628/ijhf.2020.0002
10.36628/ijhf.2020.0002 · 2020 · External reference
10.3904/kjim.2020.105
10.3904/kjim.2020.105 · 2020 · External reference
10.1007/s11914-012-0115-2
10.1007/s11914-012-0115-2 · 2012 · External reference
10.3390/jcdd12020069
10.3390/jcdd12020069 · 2025 · External reference
10.1007/s11606-025-10092-w
10.1007/s11606-025-10092-w · 2026 · External reference
10.1002/jcsm.12516
10.1002/jcsm.12516 · 2020 · External reference
10.1111/j.1524-6175.2007.6359.x
10.1111/j.1524-6175.2007.6359.x · 2007 · External reference
10.1177/10600280241282324
10.1177/10600280241282324 · 2025 · External reference
Unresolved reference
2017 · External reference
10.1016/j.bone.2025.117710
10.1016/j.bone.2025.117710 · 2026 · External reference
Unresolved reference
External reference
10.1161/jaha.122.029565
10.1161/jaha.122.029565 · 2023 · External reference
10.1002/ejhf.1976
10.1002/ejhf.1976 · 2020 · External reference
10.3389/fendo.2022.940654
10.3389/fendo.2022.940654 · 2022 · External reference
10.3389/fphar.2021.684375
10.3389/fphar.2021.684375 · 2021 · External reference
